Clinical trial condition

MSS

Explore clinical trials studying MSS. Study availability and eligibility vary by location and protocol.

13 public trials 6 recruiting studies

Refine in advanced search Browse all conditions

MSS trial results

Recruiting

ICE Study: Combination of Irinotecan Plus Cetuximab and Envafolimab as a Rechallenge Regimen in mCRC

NCT06321081

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +11 more
Locations: Beijing Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

SCRT + Chemo Targeted Immuno-neoadjuvant Therapy for High-risk pMMR/MSS RC

NCT07549399

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +11 more
Locations: Sixth Affiliated Hospital, Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Recruiting

SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases

NCT06850103

Conditions: Colonic Diseases, Colorectal Carcinoma, Colorectal Neoplasms, +13 more
Locations: The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal Cancer

NCT05731726

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +12 more
Locations: Second Affiliated Hospital School of Medicine Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors

NCT07001592

Conditions: DNA Virus Infections, Digestive System Diseases, Digestive System Neoplasms, +27 more
Locations: AHN West Penn Hospital Pittsburgh, Pennsylvania, United States

View Trial Details

Recruiting

Toripalimab Combined With Neoadjuvant Chemoradiotherapy as First-line Treatment for Locally Advanced，High-Risk，MSS Rectal Cancer

NCT05877573

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +12 more
Locations: Nanfang Hospital Southern Medical University Guangzhou, Guangdong, China

View Trial Details

Not yet recruiting

NCT + PD1 + Ketogenic Diet and/or Vitamin C for LARC

NCT07765667

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +11 more
Locations: Sixth Affiliated Hospital, Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Not yet recruiting

Lvosidenib (AK112) Combined With CapeOX and Radiotherapy in Patients With Unresectable Metastatic MSS-type Colorectal Cancer

NCT06593548

Conditions: CRC, MSS, Metastatic Cancer, +5 more
Locations: Xinxiang Li Shanghai, Shanghai Municipality, China

View Trial Details

Active, not recruiting

Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer

NCT04046445

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Cancer, +16 more
Locations: Honor Health Institute Scottsdale, Arizona, United States

University of Southern California Los Angeles, California, United States

University of Colorado Anschutz Medical Campus Aurora, Colorado, United States

NYU Langone Health New York, United States

View Trial Details

Completed

SCRT+mFOLFOX6+PD-1 Antibody and Targeted Therapy for High-Risk pMMR/MSS Rectal Cancer

NCT06908031

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +11 more
Locations: Sixth Affiliated Hospital, Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

MSS

MSS trial results

Related conditions